Patents by Inventor Matthew Whiteman

Matthew Whiteman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDEBENONE DERIVATIVES AND THEIR USE IN TREATING PLANTS
    Publication number: 20240400536
    Abstract: The invention relates to a compound of formula (I) comprising a mitochondrial targeting group linked to a group capable of releasing hydrogen sulphide for use in the treatment of the human or animal body or tissues and cells derived therefrom and to the use in the treatment of plants and to novel related compounds.
    Type: Application
    Filed: September 14, 2022
    Publication date: December 5, 2024
    Inventors: Matthew WHITEMAN, Roberta TORREGROSSA, Mark WOOD
  • Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy
    Patent number: 10149907
    Abstract: The invention relates to a combination comprising (i) a compound A comprising a mitochondrial targeting group linked to a group capable of releasing hydrogen sulfide or a pharmaceutically acceptable salt thereof or a prodrug thereof, an inhibitor of the thioredoxin antioxidant system or a pharmaceutically acceptable salt thereof or a prodrug thereof, and/or a nitroxide or a pharmaceutically acceptable salt thereof or a prodrug thereof; and (ii) a photosensitizer or photosensitizer precursor; for use in photodynamic therapy.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: December 11, 2018
    Assignee: University of Exeter
    Inventors: Mark Elliott Wood, Paul Graham Winyard, Daniel Colin Jeremy Ferguson, Matthew Whiteman, Alison Curnow, Alexis Perry
  • Hydrogen sulfide releasing compounds and their use
    Patent number: 10058100
    Abstract: The invention relates to a compound comprising a mitochondrial targeting group linked to group capable of releasing hydrogen sulfide, or a pharmaceutically acceptable salt thereof, for use in the treatment of the human or animal body by surgery or therapy. The invention also relates to the use of the compound in the treatment of a plant, and to certain forms of the compound.
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: August 28, 2018
    Assignee: The University of Exeter
    Inventors: Mark Wood, Matthew Whiteman, Alexis Perry
  • COMBINATIONS OF A PHOTOSENSITIZER WITH A HYDROGEN SULFIDE DONOR, THIOREDOXIN INHIBITOR OR NITROXIDE FOR USE IN PHOTODYNAMIC THERAPY
    Publication number: 20180161430
    Abstract: The invention relates to a combination comprising (i) a compound A comprising a mitochondrial targeting group linked to a group capable of releasing hydrogen sulfide or a pharmaceutically acceptable salt thereof or a prodrug thereof, an inhibitor of the thioredoxin antioxidant system or a pharmaceutically acceptable salt thereof or a prodrug thereof, and/or a nitroxide or a pharmaceutically acceptable salt thereof or a prodrug thereof; and (ii) a photosensitizer or photosensitizer precursor; for use in photodynamic therapy.
    Type: Application
    Filed: February 7, 2018
    Publication date: June 14, 2018
    Inventors: Mark Elliott WOOD, Paul Graham WINYARD, Daniel Colin Jeremy FERGUSON, Matthew WHITEMAN, Alison CURNOW, Alexis PERRY
  • Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy
    Patent number: 9919049
    Abstract: Compounds for use The invention relates to a combination comprising (i) a compound A comprising a mitochondrial targeting group linked to a group capable of releasing hydrogen sulfide or a pharmaceutically acceptable salt thereof or a prodrug thereof, an inhibitor of the thioredoxin antioxidant system or pharmaceutically acceptable salt thereof or a prodrug thereof, and/or a nitroxide or a pharmaceutically acceptable salt thereof or a prodrug thereof; and (ii) a photosensitizer or photosensitizer precursor; for use in photodynamic therapy.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: March 20, 2018
    Assignee: University of Exeter
    Inventors: Mark Elliott Wood, Paul Graham Winyard, Daniel Colin Jeremy Ferguson, Matthew Whiteman, Alison Curnow, Alexis Perry
  • COMBINATIONS OF A PHOTOSENSITIZER WITH A HYDROGEN SULFIDE DONOR, THIOREDOXIN INHIBITOR OR NITROXIDE FOR USE IN PHOTODYNAMIC THERAPY
    Publication number: 20170202966
    Abstract: Compounds for use The invention relates to a combination comprising (i) a compound A comprising a mitochondrial targeting group linked to a group capable of releasing hydrogen sulfide or a pharmaceutically acceptable salt thereof or a prodrug thereof, an inhibitor of the thioredoxin antioxidant system or a pharmaceutically acceptable salt thereof or a prodrug thereof, and/or a nitroxide or a pharmaceutically acceptable salt thereof or a prodrug thereof; and (ii) a photosensitizer or photosensitizer precursor; for use in photodynamic therapy
    Type: Application
    Filed: June 2, 2015
    Publication date: July 20, 2017
    Inventors: Mark Elliott WOOD, Paul Graham WINYARD, Daniel Colin Jeremy FERGUSON, Matthew WHITEMAN, Alison CURNOW, Alexis PERRY
  • HYDROGEN SULFIDE RELEASING COMPOUNDS AND THEIR USE
    Publication number: 20150196034
    Abstract: The invention relates to a compound comprising a mitochondrial targeting group linked to group capable of releasing hydrogen sulfide, or a pharmaceutically acceptable salt thereof, for use in the treatment of the human or animal body by surgery or therapy. The invention also relates to the use of the compound in the treatment of a plant, and to certain forms of the compound.
    Type: Application
    Filed: October 1, 2012
    Publication date: July 16, 2015
    Inventors: Mark Wood, Matthew Whiteman, Alexis Perry